We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
134 hedge funds and large institutions have $1.33B invested in Alder Biopharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
47% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 38
8% more capital invested
Capital invested by funds: $1.22B → $1.33B (+$103M)
7% more call options, than puts
Call options by funds: $3.69M | Put options by funds: $3.43M
4% less funds holding
Funds holding: 140 → 134 (-6)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
134
Holders Change
-6
Holders Change %
-4.29%
% of All Funds
3.52%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
18
Increased
56
Reduced
38
Closed
23
Calls
$3.69M
Puts
$3.43M
Net Calls
+$251K
Net Calls Change
+$6.63M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$24.2M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$16.8M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$13.7M |
| 4 |
Morgan Stanley
New York
|
-$7.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.63M |
